MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Medline Inc.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)
Close on Oct 19, 2026
- Market cap
- $30.29B
- P/E (TTM)
- –
- Dividend yield
- –
Medline Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| Supply Chain Solutions | $14.71B | $12.99B | $11.62B | 51.7% | +13.2% |
| Medline Brand | $13.72B | $12.52B | $11.61B | 48.3% | +9.6% |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| United States | $26.48B | $23.75B | $21.80B | 93.1% | +11.5% |
| International | $1.95B | $1.76B | $1.43B | 6.9% | +11.0% |
From the segment and revenue-disaggregation notes of Medline's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.